comparemela.com

Latest Breaking News On - Alessandro doria - Page 1 : comparemela.com

JDRF Awards $9 Million US for Phase 3 Type 1 Diabetes Kidney Disease

EBRD expands Youth in Business programme in Albania

North Carolina Museum of Art celebrates record attendance, new acquisitions

Intensive Blood Glucose & Blood Pressure Control in Diabetics Reduces CAN Risk

Intensive Blood Glucose & Blood Pressure Control in Diabetics Reduces CAN Risk by Iswarya on  December 17, 2020 at 12:22 PM Intensive interventions to reduce blood glucose and blood pressure levels in type 2 diabetes decrease the risk of developing cardiovascular autonomic neuropathy (CAN), a frequent but underdiagnosed complication of diabetes that can be life-threatening, reports a new study. The findings of the study are published in the journal Diabetes Care. The study is led by Alessandro Doria, MD, PhD, MPH, from the Joslin Diabetes Center and Harvard Medical School, and Rodica Pop Busui, MD, PhD. They also found that intensive control of blood glucose was more effective in individuals with no history of cardiovascular disease (CVD) and that blood pressure lowering was more effective in individuals older than 65 years, suggesting that some degree of personalization of risk reduction might be possible.

Intensive interventions in type 2 diabetes reduce risk of cardiovascular autonomic neuropathy

Intensive interventions in type 2 diabetes reduce risk of cardiovascular autonomic neuropathy Intensive interventions to reduce blood glucose and blood pressure levels in type 2 diabetes reduce the risk of developing cardiovascular autonomic neuropathy (CAN), a frequent but underdiagnosed complication of diabetes that can be life-threatening. In a study led by Alessandro Doria , MD, PhD, MPH, from the Joslin Diabetes Center and Harvard Medical School, and Rodica Pop Busui, MD, PhD, of the University of Michigan, published online in Diabetes Care , researchers found that intensive glycemic control reduced CAN risk by 17%, while intensive blood pressure control reduced risks by 22%. They also found that intensive control of blood glucose was more effective in individuals with no history of cardiovascular disease (CVD) and that blood pressure lowering was more effective in individuals older than 65 years, suggesting that some degree of personalization of risk reduction might be p

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.